Postconditioning: A brief review

Archives of Medical Science

Volumn 2, Issue 3, 2006, Pages 137-145

  Schipke, Jochen D ^a   Halkos, Michael E ^b   Kerendi, Faraz ^b   Gams, Emmeran ^a   Vinten Johansen, Jacob ^b  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardioprotection; Ischemia reperfusion; Remote postconditioning; Remote preconditioning; Reperfusion injury; Reperfusion therapeutics

Indexed keywords

8 4 SULFOPHENYLTHEOPHYLLINE; ADENOSINE; ADENOSINE RECEPTOR BLOCKING AGENT; BRADYKININ; COMPLEMENT INHIBITOR; CYTOKINE; DIAZOXIDE; NITRIC OXIDE; OPIATE; OXYGEN RADICAL; PROSTAGLANDIN; THEOPHYLLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANESTHESIA; APOPTOSIS; BLOOD FLOW; CELL TYPE; CONDITIONING; CORONARY REPERFUSION; HEART INFARCTION SIZE; HEART MUSCLE NECROSIS; HEART PROTECTION; HUMAN; ISCHEMIA; KIDNEY ARTERY STENOSIS; REPERFUSION INJURY; REVIEW; VASCULAR ENDOTHELIUM;

EID: 33750605098     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124-36.
2. Post H, Heusch G. Ischemic preconditioning. Experimental facts and clinical perspective. Minerva Cardioangiol 2002; 50: 569-605.
3. Vaage J, Valen G. Preconditioning and cardiac surgery. Ann Thorac Surg 2003; 75: 5709-14.
4. Chiari P, Bouvet F, Piriou V. Anaesthetic-induced myocardial preconditioning: fundamental basis and clinical implications. Ann Fr Anesth Reanim 2005; 24: 383-96.
5. Perrault IP, Menasche P. Preconditioning: can nature's shield be raised against surgical ischemic-reperfusion injury? Ann Thorac Surg 1999; 68: 1988-94.
6. Przyklenk K, Darling CE, Dickson EW, Whittaker P. Cardioprotection Outside the box' - the evolving paradigm of remote preconditioning. Basic Res Cardiol 2003; 98: 149-57.
7. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, Vinten-Johansen J. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 2003; 285: H579-88.
8. Yellon DM, Opie LH. Postconditioning for protection of the infarcting heart. Lancet 2006; 367: 456-8.
9. Vinten-Johansen J, Zhao ZQ, Zatta AJ, Kin H, Halkos ME, Kerendi F. Postconditioning - A new link in nature's armor against myocardial ischemia-reperfusion injury. Basic Res Cardiol 2005; 100: 295-310.
10. Vinten-Johansen J, Yellon DM, Opie LH. Postconditioning: a simple, clinically applicable procedure to improve revascularization in acute myocardial infarction. Circulation 2005; 112: 2085-8.
11. Vinten-Johansen J, Zhao ZQ, Jiang R, Zatta AJ. Myocardial protection in reperfusion with postconditioning. Expert Rev Cardiovasc Ther 2005; 3: 1035-45.
12. Feng J, Lucchinetti E, Ahuja P, Pasch T, Perriard JC, Zaugg M. Isoflurane postconditioning prevents opening of the mitochondrial permeability transition pore through inhibition of glycogen synthase kinase 3beta. Anesthesiology 2005; 103: 987-95.
13. Weber NC, Preckel B, Schlack W. The effect of anaesthetics on the myocardium-new insights into myocardial protection. Eur J Anaesthesiol 2005; 22: 647-57.
14. Chiari PC, Bienengraeber MW, Pagel PS, Krolikowski JG, Kersten JR, Warltier DC. Isoflurane protects against myocardial infarction during early reperfusion by activation of phosphatidylinositol-3-kinase signal transduction: evidence for anesthetic-induced postconditioning in rabbits. Anesthesiology 2005; 102: 102-9.
15. Sun HY, Wang NP, Kerendi F, Halkos M, Kin H, Guyton RA, Vinten-Johansen J, Zhao ZQ. Hypoxic postconditioning reduces cardiomyocyte loss by inhibiting ROS generation and intracellular Ca2+ overload. Am J Physiol Heart Circ Physiol 2005; 288: H1900-8.
16. Tsang A, Hausenloy DJ, Mocanu MM, Yellon DM. Postconditioning: a form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway. Circ Res 2004; 95: 230-2.
17. Heusch G, Buchert A, Feldhaus S, Schulz R. No loss of cardioprotection by postconditioning in connexin 43-deficient mice. Basic Res Cardiol 2006; 101: 354-6.
18. Kin H, Zhao ZQ, Sun HY, Wang NP, Corvera JS, Halkos ME, Kerendi F, Guyton RA, et al. Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion. Cardiovasc Res 2004; 62: 74-85.
19. Yang XM, Proctor JB, Cui L, Krieg T, Downey JM, Cohen MV. Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways. J Am Coll Cardiol 2004; 44: 1103-10.
20. Jiang R, Reeves JG, Mykytenko J et al. Postconditioning reduces reperfusion injury by inhibiting the tissue factor-thrombin pathway in a closed-chest porcine model of ischemia-reperfusion. Circulation 2005; 112 (Suppl II), II-309 (Abstract).
21. Halkos ME, Kerendi F, Corvera JS, Wang NP, Kin H, Payne CS, et al. Myocardial protection with postconditioning is not enhanced by ischemic preconditioning. Ann Thorac Surg 2004; 78: 961-9.
22. Staat P, Rioufol G, Piot C, Cottin Y, Cung TT, L'Huillier I, et al. Postconditioning the human heart. Circulation 2005; 112: 2143-8.
23. Serviddio G, Di Venosa N, Federici A, D'Agostino D, Rollo T, Prigigallo F, et al. Brief hypoxia before normoxic reperfusion (postconditioning) protects the heart against ischemia-reperfusion injury by preventing mitochondria peroxyde production and glutathione depletion. FASEB J 2005; 19: 354-61.
24. Kin H, Zatta AJ, Jiang R et al. Activation of opioid receptors mediates the infarct size reduction by postconditioning. J Mol Cell Cardiol 2005; 38, 827 (Abstract).
25. Todd JC, Zhao ZQ, Williams MW, Sato H, Van Wylen DG, Vinten-Johansen J. Intravascular adenosine at reperfusion reduces infarct size and neutrophil adherence. Ann Thorac Surg 1996; 62: 1364-72.
26. Todd JC, Williams MW, Zhao ZQ, Sato H, Jordan JE, Vinten-Johansen J. Polyadenylic acid reduces infarkt size via intravascular adenosine receptor mechanisms during reperfusion. FASEB J 1995; 9, A421 (Abstract).
27. Darling CE, Jiang R, Maynard M, Whittaker P, Vinten-Johansen J, Przyklenk K. Postconditioning via stuttering reperfusion limits myocardial infarct size in rabbit hearts: role of ERK1/2. Am J Physiol Heart Circ Physiol 2005; 289: H1618-26.
28. Schwartz LM, Lagranha CJ. Ischemic postconditioning during reperfusion activates Akt and ERK without protecting against lethal myocardial ischemia-reperfusion injury in pigs. Am J Physiol Heart Circ Physiol 2006; 290: H1011-8.
29. Kerendi F, Kin H, Halkos ME, Jiang R, Zatta AJ, Zhao ZQ, et al. Remote postconditioning. Brief renal ischemia and reperfusion applied before coronary artery reperfusion reduces myocardial infarct size via endogenous activation of adenosine receptors. Basic Res Cardiol 2005; 100: 404-12.
30. Laskey WK. Brief repetitive balloon occlusions enhance reperfusion during percutaneous coronary intervention for acute myocardial infarction: a pilot study. Catheter Cardiovasc Interv 2005; 65: 361-7.
31. Gumina RJ, Gross GJ. If ischemic preconditioning is the gold standard, has a platinum standard of cardioprotection arrived? Comparison with NHE inhibition. J Thromb Thrombolysis 1999; 8: 39-44.
32. Diaz RJ, Wilson GJ. Modifying the first minute of reperfusion: potential for myocardial salvage. Cardiovasc Res 2004; 62: 4-6.
33. Chan RK, Ibrahim SI, Verna N, Carroll M, Moore FD, Jr., Hechtman HB. Ischaemia-reperfusion is an event triggered by immune complexes and complement. Br J Surg 2003; 90: 1470-8.
34. Lucchinetti E, da Silva R, Pasch T, Schaub MC, Zaugg M. Anaesthetic preconditioning but not postconditioning prevents early activation of the deleterious cardiac remodelling programme: evidence of opposing genomic responses in cardioprotection by pre- and postconditioning. Br J Anaesth 2005; 95: 140-52.
35. Heusch G. Postconditioning: old wine in a new bottle? J Am Coll Cardiol 2004; 44: 1111-2.